Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib

Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with clinical response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib, in patients with non-small cell lung cancer (NSCLC). However, humoral immune responses to EGFR in NSCLC patients have not been wel...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Azuma, Koichi, Komatsu, Nobukazu, Hattori, Satoshi, Matsueda, Satoko, Kawahara, Akihiko, Sasada, Tetsuro, Itoh, Kyogo, Hoshino, Tomoaki
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3909003/
https://ncbi.nlm.nih.gov/pubmed/24497964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0086667
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky